| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2023 | Mar 6, 2023 | Quince Therapeutics, Inc. | Chief Accounting Officer & VP | Sell | 37.5 | -1,871 | -6.38% | ✓ | $1.8K |
| Dec 5, 2022 | Dec 7, 2022 | Quince Therapeutics, Inc. | Chief Accounting Officer & VP | Sell | 37.5 | -1,640 | -5.30% | ✓ | $1.2K |
| Sep 6, 2022 | Sep 8, 2022 | Quince Therapeutics, Inc. | Chief Accounting Officer & VP | Sell | 42.5 | -1,520 | -4.68% | ✓ | $2.5K |
| Jun 6, 2022 | Jun 8, 2022 | Quince Therapeutics, Inc. | Chief Accounting Officer & VP | Sell | 42.5 | -1,529 | -4.50% | ✓ | $4.8K |